Page 28 - Biomarkers for risk stratification and guidance in heart failure
P. 28
Multimarker risk score in emergency department dyspnea
2 markers elevated
3 markers elevated
N Value N
125 78± 12 119
125 74 (62.2%) 119
125 49 (41.2%) 119
45 34 (69.4%) 49
125 61 (51.3%) 119
121 39 (34.5%) 113
124 45 (38.1%) 118
125 34 (28.6%) 119
99 65 (64.4%) 101
67 35 (25-50) 74
125 57 (47.9%) 119
119 134±30.0 117
119 71.3±15.6 117
125 93.5± 28.9 119
107 112± 30.6 109
125 12.1± 2.1 118
125 1.7 (1.2 – 2.4) 119
124 33.3 119 (21.6 – 51.8)
125 24.6 (8.3 - 66.4) 119
125 0.063 119 (0.044 - 0.109)
125 1.62 119 ( 1.20 - 2.34)
125 9,347 119 (4,924 - 15,907)
125 30 (24 - 39) 119 122 84 (71.2%) 118 122 67 (56.8%) 118 122 67 (56.8%) 118 122 8 (6.8%) 118 122 53 (44.9%) 118 122 23 (19.5%) 118
125 94 (79.0%) 119 125 0 (0%) 119 125 5 (4.2%) 119 125 11 (9.2%) 119 125 6 (5.0%) 119 125 3 (2.5%) 119
4 markers elevated P-value
Value N
81± 7 55 <0.001
35 (63.6%) 55 0.211
32 (58.2%) 55 <0.001
21 (65.6%) 32 0.178
30 (54.5%) 55 0.189
17 (32.1%) 53 0.159
20 (36.4%) 55 0.294
9 (16.7%) 54 0.317
33 (71.7%) 46 0.410
40 (26-48) 33 0.001
26 (47.3%) 55 0.033
124±29.3 50 <0.001
68.3± 17.1 50 <0.001
96.6± 29.2 54 0.925
116± 31.0 46 0.030
11.9± 1.9 55 <0.001
2.0 (1.5 – 2.8) 55 <0.001
45.1 55 <0.001 (34.5 – 67.5)
72.5 (37.7 - 137.0) 55 <0.001
0.096 55 <0.001 (0.057 - 0.23)
1.79 55 <0.001 (1.47 - 2.57)
17,601 55 <0.001 (9,805 - 25,085)
36 (30 - 54) 55 <0.001 40 (72.7%) 55 <0.001 27 (49.1%) 55 0.663 36 (65.5%) 55 0.578 7 (12.7%) 55 0.367 23 (41.8%) 55 0.279 10 (18.2%) 55 0.061
43 (78.2%) 55 <0.001 6 (10.9%) 55 0.014 1 (1.8%) 55 0.413 3 (5.5%) 55 0.910 1 (1.8%) 55 0.089 1 (1.8%) 55 <0.001
Value
78± 9
67 (53.6%)
45 (36.0%)
27 (60.0%)
49 (39.2%)
38 (31.4%)
37 (29.8%)
25 (20.0%)
74 (74.7%)
45 (25-58)
42 (33.6%)
137±28.0
73.1± 17.1
93.7± 31.5
111± 35.9
12.2±1.9
1.3 (1.1 – 1.7)
25.2
(18.8 – 35,0)
16.8 (5.4 - 40.9)
0.036
(0.024 - 0.062)
1.24
(1.07 - 1.67)
4,864
(2,127 - 8,352)
24 (19 - 32) 78 (63.9%) 68 (55.7%) 64 (52.5%) 13 (10.7%) 42 (34.4%) 12 (9.8%)
81 (64.8%) 11 (8.8%) 4 (3.2%)
9 (7.2%) 10 (8.0%) 10 (8.0%)
2
27
